TherapeuticsMD(TXMD) - 2020 Q3 - Earnings Call Transcript

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Nichol Ochsner – Vice President of Investor Relations Robert Finizio – Chief Executive Officer James D’Arecca – Chief Financial Officer Dawn Halkuff – Chief Commercial Officer Mitchell Krassan – Chief Strategy and Performance Officer Conference Call Participants Nick Rubino – Stifel Carvey Leung – Cantor Fitzgerald Stacy Ku – Cowen and Company Douglas Tsao – H.C. Wainwright Dana Flanders – Gu ...